If you are working with controlled substances, it’s imperative to stay abreast of the developments in the DEA enforcement, as well as of any updates and changes in the arena. I will be teaching a webinar with the DEA and William Keane on December 12.

Overview of the webinar:

The webinar will review the recent landscape of administrative, civil and criminal actions brought and penalties obtained by U.S. Attorney’s Offices and the Drug Enforcement Administration (DEA) involving violations of the Controlled Substances Act and related rules in the Code of Federal Regulations, including investigative techniques such as audits and administrative warrants the DEA regularly employs. The webinar also will address the requirements when prescribing through TeleHealth, trends in state Prescription Drug Monitoring Programs laws, applicability of medical marijuana laws to hospitals and will discuss best practices to follow for hospital pharmacies in assuring compliance with controlled substances laws. The panelist for the webinar intend to review practical tips for responding to such investigative techniques, and discuss the best strategies to avoid DEA audits or potential revocation/suspension of DEA registrations.